Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

Amgen

8 posts
NNovo Nordisk
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)
Read More

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)

  • 2026-08-16
Demand for GLP-1 drugs is exploding. While medicines in this category traditionally treated diabetes, they are now being…
NNovo Nordisk
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)
Read More

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)

  • 2026-08-15
Demand for GLP-1 drugs is exploding. While medicines in this category traditionally treated diabetes, they are now being…
NNovo Nordisk
Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients
Read More

Watch Out, Eli Lilly and Novo Nordisk: Amgen’s Monthly Weight Loss Drug Has 6 Phase 3 Trials Running — and It’s Coming for Your Patients

  • 2026-07-29
Amgen (NASDAQ: AMGN) is betting that the convenience of its weight loss treatment will make it a winner,…
NNovo Nordisk
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
Read More

In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s

  • 2026-07-16
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
NNovo Nordisk
Telegram
Read More

Novo Nordisk CEO Dustar: Obesity Has Eclipsed Diabetes at ADA as Lilly’s Retatrutide Hits 28.3% Weight Loss — BigGo Finance

  • 2026-07-10
When the chief executive of the world’s most valuable obesity-drug company admits he’s surprised that a diabetes conference…
NNovo Nordisk
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?
Read More

Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?

  • 2026-05-27
Novo Nordisk NVO and Amgen AMGN are both global healthcare heavyweights with the scale, financial strength and research depth…
NNovo Nordisk
Better Weight Loss Stock: Novo Nordisk Vs. Amgen
Read More

Better Weight Loss Stock: Novo Nordisk Vs. Amgen

  • 2026-03-11
The weight-loss market has become one of the most active therapeutic areas in the pharmaceutical industry over the…
NNovo Nordisk
The Motley Fool
Read More

Better Weight Loss Stock: Novo Nordisk Vs. Amgen

  • 2026-03-09
Key Points Novo Nordisk is a top player in the weight loss market and has several more products…
Denmark
www.europesays.com